Skip to main content
OpenTrials

Clinical trial condition

Hematologic Neoplasms

Explore clinical trials studying Hematologic Neoplasms. Study availability and eligibility vary by location and protocol.

1,027 public trials 268 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Neoplasms trial results

Completed

Expanded Access of Omidubicel, for Allogeneic Transplantation in Patients With Hematological Malignancies

NCT04260698

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +3 more
Locations
  • UCLA Los Angeles, California, United States
  • Stanford University Cancer Institute Palo Alto, California, United States
  • Loyola University, Cardinal Bernardin Cancer Center Maywood, Illinois, United States
  • University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, United States
View Trial Details
Completed

A Study of Teclistamab in Japanese Participants With Relapsed or Refractory Multiple Myeloma

NCT04696809

Conditions
Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +3 more
Locations
  • Kameda Medical Center Chiba, Japan
  • Ogaki Municipal Hospital Gifu, Japan
  • National Hospital Organization Mito Medical Center Higashiibaraki-gun, Japan
  • Kobe City Medical Center General Hospital Kobe, Japan
View all 15 locations
View Trial Details
Completed

Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies

NCT04552288

Conditions
Hematologic Diseases, Hematologic Malignancy, Hematologic Neoplasms, +6 more
Locations
  • Memorial Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
  • Memorial Sloan Kettering Westchester Harrison, New York, United States
  • Memorial Sloan Kettering Cancer Center Suffolk - Hauppauge (Limited Protocol Activities) Hauppauge, New York, United States
View Trial Details

Related conditions